Clinical Trials Logo

Clinical Trial Summary

This study was to test an optimal concentration of Lugol's solution which can reduce the mucosal irritation and provide high image quality to ensure endoscopy examination by a randomized blinded controlled trial.


Clinical Trial Description

It is widely accepted that chromoendoscopy using Lugol's solution is effective for the detection of early esophageal squamous neoplasia. However, this modality may cause severe chest pain and discomfort owing to mucosal irritation. The conventional concentration of Lugol's solution is in the range of 1.2% to 2.5% . Image quality can be guaranteed with this range of Lugol's solution. However, lead to retrosternal pain and discomfort, and can even induce erosion or ulceration in the esophagus and stomach. This study was to test whether a lower concentration of Lugol's solution, which has minimal mucosal irritation, can provide satisfied image quality by a randomized blinded controlled trial. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03180944
Study type Interventional
Source Shandong University
Contact
Status Completed
Phase Phase 2
Start date September 1, 2017
Completion date December 30, 2018

See also
  Status Clinical Trial Phase
Completed NCT03425032 - Low-dose Whole Body Computed Tomography Scanning
Completed NCT03812185 - TEE Image Quality Improvement With Our Devised Probe Cover N/A
Recruiting NCT02519920 - Lower Fluorescein Sodium Dose on Confocal Laser Endoscopy Image Quality and Yellow Discoloration of the Skin Phase 2